254 related articles for article (PubMed ID: 27015572)
1. Comparison of Subtenon Triamcinolone Acetonide Injection with Topical Nepafenac for the Treatment of Pseudophakic Cystoid Macular Edema.
Yüksel B; Uzunel UD; Kerci SG; Sağban L; Küsbeci T; Örsel T
Ocul Immunol Inflamm; 2017 Aug; 25(4):513-519. PubMed ID: 27015572
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the Efficacy of Dexamethasone, Nepafenac, and Bromfenac for Preventing Pseudophakic Cystoid Macular Edema: an Open-label, Prospective, Randomized Controlled Trial.
Campa C; Salsini G; Perri P
Curr Eye Res; 2018 Mar; 43(3):362-367. PubMed ID: 29120255
[TBL] [Abstract][Full Text] [Related]
3. Topical nepafenac as an alternate treatment for cystoid macular edema in steroid responsive patients.
Warren KA; Fox JE
Retina; 2008; 28(10):1427-34. PubMed ID: 18664937
[TBL] [Abstract][Full Text] [Related]
4. Resolution of Pseudophakic Cystoid Macular Edema: 2 mg Intravitreal Triamcinolone Acetonide versus 40 mg Posterior Sub-Tenon Triamcinolone Acetonide.
Kuley B; Storey PP; Wibbelsman TD; Pancholy M; Zhang QE; Sharpe J; Bello N; Obeid A; Regillo C; Kaiser RS; Chiang A; Fineman MS; Vander JF; Gupta OP; Spirn MJ; Dunn JP; Mehta S; Park CH; Maguire JI; Garg S
Curr Eye Res; 2021 Jun; 46(6):824-830. PubMed ID: 33522311
[TBL] [Abstract][Full Text] [Related]
5. NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema.
Warren KA; Bahrani H; Fox JE
Retina; 2010 Feb; 30(2):260-6. PubMed ID: 20175270
[TBL] [Abstract][Full Text] [Related]
6. Factors predicting response of pseudophakic cystoid macular edema to topical steroids and nepafenac.
Sengupta S; Vasavada D; Pan U; Sindal M
Indian J Ophthalmol; 2018 Jun; 66(6):827-830. PubMed ID: 29785993
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal triamcinolone acetonide in refractory pseudophakic cystoid macular edema: functional and anatomic results.
Boscia F; Furino C; Dammacco R; Ferreri P; Sborgia L; Sborgia C
Eur J Ophthalmol; 2005; 15(1):89-95. PubMed ID: 15751245
[TBL] [Abstract][Full Text] [Related]
8. Posterior subtenon injection of triamcinolone acetonide after phacoemulsification in a patient with X-linked retinoschisis.
Wang JK; Lin WC
Optom Vis Sci; 2013 Oct; 90(10):e274-7. PubMed ID: 23974665
[TBL] [Abstract][Full Text] [Related]
9. Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery.
Miyake K; Ota I; Miyake G; Numaga J
J Cataract Refract Surg; 2011 Sep; 37(9):1581-8. PubMed ID: 21855758
[TBL] [Abstract][Full Text] [Related]
10. Topical dexamethasone γ-cyclodextrin nanoparticle eye drops increase visual acuity and decrease macular thickness in diabetic macular oedema.
Ohira A; Hara K; Jóhannesson G; Tanito M; Ásgrímsdóttir GM; Lund SH; Loftsson T; Stefánsson E
Acta Ophthalmol; 2015 Nov; 93(7):610-5. PubMed ID: 26201996
[TBL] [Abstract][Full Text] [Related]
11. A prospective randomized clinical trial comparing nepafenac, intravitreal triamcinolone and no adjuvant therapy for epiretinal membrane.
Mandelcorn ED; Al-Falah M; Zhao LD; Kertes P; Devenyi R; Lam WC
Acta Ophthalmol; 2022 Feb; 100(1):e297-e303. PubMed ID: 33847066
[TBL] [Abstract][Full Text] [Related]
12. Effect of Posterior Subtenon Triamcinolone Acetonide Injection on Diabetic Macular Edema Refractory to Intravitreal Bevacizumab Injection.
Kim MW; Moon H; Yang SJ; Joe SG
Korean J Ophthalmol; 2016 Feb; 30(1):25-31. PubMed ID: 26865800
[TBL] [Abstract][Full Text] [Related]
13. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
14. Pseudophakic cystoid macular edema prevention and risk factors; prospective study with adjunctive once daily topical nepafenac 0.3% versus placebo.
McCafferty S; Harris A; Kew C; Kassm T; Lane L; Levine J; Raven M
BMC Ophthalmol; 2017 Feb; 17(1):16. PubMed ID: 28219426
[TBL] [Abstract][Full Text] [Related]
15. Intraocular triamcinolone acetonide for pseudophakic cystoid macular edema: optical coherence tomography and multifocal electroretinography study.
Koutsandrea C; Moschos MM; Brouzas D; Loukianou E; Apostolopoulos M; Moschos M
Retina; 2007 Feb; 27(2):159-64. PubMed ID: 17290196
[TBL] [Abstract][Full Text] [Related]
16. Intravitreal triamcinolone compared with macular laser grid photocoagulation for the treatment of cystoid macular edema.
Avitabile T; Longo A; Reibaldi A
Am J Ophthalmol; 2005 Oct; 140(4):695-702. PubMed ID: 16226521
[TBL] [Abstract][Full Text] [Related]
17. Early treatment of severe cystoid macular edema in central retinal vein occlusion with posterior sub-tenon triamcinolone acetonide.
Lin JM; Chiu YT; Hung PT; Tsai YY
Retina; 2007 Feb; 27(2):180-9. PubMed ID: 17290200
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.
Bae JH; Lee CS; Lee SC
Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170
[TBL] [Abstract][Full Text] [Related]
19. Intravitreal versus posterior subtenon injection of triamcinolone acetonide for diabetic macular edema.
Choi YJ; Oh IK; Oh JR; Huh K
Korean J Ophthalmol; 2006 Dec; 20(4):205-9. PubMed ID: 17302204
[TBL] [Abstract][Full Text] [Related]
20. Short-term outcomes of subtenon triamcinolone acetonide injections in patients with retinitis pigmentosa-associated cystoid macular edema unresponsive to carbonic anhydrase inhibitors.
Karasu B
Int Ophthalmol; 2020 Mar; 40(3):677-687. PubMed ID: 31773389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]